RxDoctor Payments DataLook up a doctor →

Roberto Saez, MD

Internal Medicine · Bentonville, ARNPI 1811925910

Payments from drug & device makers

$8,495in general payments, 2019–2025

Across 625 payments — averaging $13.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • GSK$767
  • Amgen$755
  • Abbott$561
  • Pfizer$558
  • Novo Nordisk$431
  • plus $4K from 40 others

What the payments were for

  • Food & beverage$8,488100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,495 in reported general payments places this provider in the 90th percentile of 614 internal medicine providers in Arkansas.

See all internal medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$144,364
Medicare patients
361
Services billed
5,495

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide123$188,355
FarxigaDapagliflozin Propanediol93$103,265
EliquisApixaban91$84,332
JardianceEmpagliflozin45$55,339
XareltoRivaroxaban58$50,145
MounjaroTirzepatide30$35,352
Tresiba Flextouch U-200Insulin Degludec14$28,300
MyrbetriqMirabegron37$25,983
JanuviaSitagliptin Phosphate16$21,103
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$14,122
Breo ElliptaFluticasone/Vilanterol24$11,909
Atorvastatin Calcium813$6,216
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$5,923
Gabapentin261$4,805
Fluticasone-SalmeterolFluticasone Propion/Salmeterol28$4,634

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$431$188,355123 claims
AstraZenecaFarxiga$333$103,26593 claims
PfizerEliquis$558$84,33291 claims
Boehringer IngelheimJardiance$207$55,33945 claims
Johnson & JohnsonXarelto$352$50,14558 claims
Lilly USA, LLCMounjaro$147$35,35230 claims
GSKTrelegy Ellipta, Breo Ellipta$767$26,03136 claims
Astellas Pharma US IncMyrbetriq$305$25,98337 claims
MerckJanuvia$119$21,10316 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$15$4,532580 claims
AbbVieSynthroid$1,645$1,78028 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 614 internal medicine providers in Arkansas.

Other internal medicine in Bentonville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →